Morran, Douglas C., Wu, Jianmin, Australian Pancreatic Cancer Genome Initiative,, Oien, Karin A., McKay, Colin J., Carter, C. Ross, Gillen, Gerry, Champion, Sue, Pimlott, Sally L., Anderson, Kurt I., Evans, T. R. Jeffry, Grimmon , Sean M., Jamieson, Nigel B., Biankin, Andrew V., Samson, Owen J., Morton, Jennifer P., Mrowinska, Agata, Kalna, Gabriela, Karim, Saadia A., Au, Amy Y. M., Scarlett, Christopher J., Chang, David K., Pajak, Malgorzata Z.. BMJ Group; 2014. Targeting mTOR dependency in pancreatic cancer.

Humphris, Jeremy L., Johns, Amber L., Mead, R. Scott, Gill, Anthony J., Samra, Jaswinder S., Kench, James G., Musgrove, Elizabeth A., Tucker, Katherine M., Spigelman, Allan D., Waddell, Nic, Grimmond, Sean M., Biankin, Andrew V. Biankin, Simpson, Skye H., Australian Pancreatic Cancer Genome Initiative,, Cowley, Mark J., Pajic, Marina, Chang, David K., Nagrial, Adnan M., Chin, Venessa T., Chantrill, Lorraine A., Pinese, Mark. Wiley-Blackwell Publishing; 2014. Clinical and pathologic features of familial pancreatic cancer.

Gingras, Marie-Claude, Covington, Kyle R., Fisher, William E., Pilarsky, Christian, Grützmann, Robert, Overman, Michael J., Jamieson, Nigel B., Van Buren II, George, Drummond, Jennifer, Walker, Kimberly, Hampton, Oliver A., Australian Pancreatic Cancer Genome Initiative,, Chang, David K., Wong, Rachel, Donehower, Lawrence A., Gill, Anthony J., Ittmann, Michael M., Creighton, Chad J., Johns, Aamber L., Shinbrot, Eve, Dewal, Ninad. Elsevier; 2016. Ampullary cancers harbor ELF3 tumor suppressor gene mutations and exhibit frequent WNT dysregulation.